Dagimawie Tadesse
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dagimawie Tadesse has a total of 137 co-authors. Here are the top co-authors by number of shared publications:
Tamiru Shibiru Degaga
4 shared publicationsAsrat Hailu
College of Medicine and Health Sciences, Arba Minch University, Arba Minch, Ethiopia
3 shared publications- Asrat Hailu
Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
3 shared publications Johan van Griensven
Clinical Sciences Department, Institute of Tropical Medicine, Antwerp, Belgium
3 shared publications- Mohammad Shafiul Alam
Infectious Diseases Division Dhaka International Centre for Diarrheal Diseases Research
3 shared publications Agustina Dal Molin Veglia
Clinical Sciences Department, Institute of Tropical Medicine
2 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Springer Nature in Research Square
Decentralization of diagnosis and management of skin diseases at primary hospitals in southern Ethiopia
Background Skin diseases are a major cause of morbidity in low- and middle-income countries, where access to dermatologic care is limited. As Ethiopia expands decentralized integrated skin disease services to primary hospitals in line with the World Health Organization's (WHO) roadmap for neglected tropical diseases (NTDs), we evaluated healthcare professionals' training outcomes and the diagnostic and management concordance of skin disease care at the primary hospital level in southern Ethiopia. Methods We conducted an implementation study between Sept 1, 2023, and Dec 31, 2024, at two primary hospitals in southern Ethiopia. Clinical and laboratory professionals received standardized training on the diagnosis and treatment of skin diseases as part of a decentralization initiative. Pre- and post-training knowledge assessments were conducted. Skin disease diagnostic and management concordance between primary hospital physicians and dermatologists' reference evaluations was assessed using proportions with 95% confidence intervals (CIs) and visualizations with concordance matrix heat maps. Findings: Of 1,163 screened patients, 1,114 were included; 626 (56.0%) were younger than 14 years. Training improved knowledge among clinical professionals by 19.5 percentage points (95% CI: 13.7–25.3, p < 0.001) and laboratory professionals by 23.4 percentage points (95% CI: 9.3–37.5, p = 0.01). Overall diagnostic concordance was 67.4% (743/1103, 95% CI: 64.5%–70.1%), highest for cutaneous leishmaniasis (CL) (96 cases, 94.1%, 95% CI: 89.5%–98.7%) and scabies (75, 90.4%, 95% CI: 84.0%–96.8%), and lowest for inflammatory dermatoses (195, 70.9%, 95% CI: 65.5%–76.3%) and fungal infections (113, 60.4%, 95% CI: 53.4%–67.4%). Among patients who were correctly diagnosed, management concordance was 91.3% (678/743; 95% CI: 88.9%–93.2%). Interpretation: Diagnostic correctness, rather than patient management, remains the principal bottleneck in decentralized skin disease care. Sustainable decentralization will require ongoing training, supportive supervision, specialist support, and (electronic) diagnostic decision-support tools, particularly for fungal and inflammatory dermatoses.
- 1 September 2026
- Published by Springer Nature in Research Square
Open AccessDecentralization of diagnosis and management of skin diseases at primary hospitals in southern Ethiopia
Background Skin diseases are a major cause of morbidity in low- and middle-income countries, where access to dermatologic care is limited. As Ethiopia expands decentralized integrated skin disease services to primary hospitals in line with the World Health Organization's (WHO) roadmap for neglected tropical diseases (NTDs), we evaluated healthcare professionals' training outcomes and the diagnostic and management concordance of skin disease care at the primary hospital level in southern Ethiopia. Methods We conducted an implementation study between Sept 1, 2023, and Dec 31, 2024, at two primary hospitals in southern Ethiopia. Clinical and laboratory professionals received standardized training on the diagnosis and treatment of skin diseases as part of a decentralization initiative. Pre- and post-training knowledge assessments were conducted. Skin disease diagnostic and management concordance between primary hospital physicians and dermatologists' reference evaluations was assessed using proportions with 95% confidence intervals (CIs) and visualizations with concordance matrix heat maps. Findings: Of 1,163 screened patients, 1,114 were included; 626 (56.0%) were younger than 14 years. Training improved knowledge among clinical professionals by 19.5 percentage points (95% CI: 13.7–25.3, p < 0.001) and laboratory professionals by 23.4 percentage points (95% CI: 9.3–37.5, p = 0.01). Overall diagnostic concordance was 67.4% (743/1103, 95% CI: 64.5%–70.1%), highest for cutaneous leishmaniasis (CL) (96 cases, 94.1%, 95% CI: 89.5%–98.7%) and scabies (75, 90.4%, 95% CI: 84.0%–96.8%), and lowest for inflammatory dermatoses (195, 70.9%, 95% CI: 65.5%–76.3%) and fungal infections (113, 60.4%, 95% CI: 53.4%–67.4%). Among patients who were correctly diagnosed, management concordance was 91.3% (678/743; 95% CI: 88.9%–93.2%). Interpretation: Diagnostic correctness, rather than patient management, remains the principal bottleneck in decentralized skin disease care. Sustainable decentralization will require ongoing training, supportive supervision, specialist support, and (electronic) diagnostic decision-support tools, particularly for fungal and inflammatory dermatoses.
- Open Access
- 3 August 2026
- Published by Elsevier in SSRN Electronic Journal
Lesion Associated Bacterial Dysbiosis in Patients with Cutaneous Leishmaniasis in Ethiopia
Background: Cutaneous leishmaniasis (CL) is a chronic skin disease frequently complicated by bacterial superinfection and poor treatment outcomes. Lesion-associated bacterial dysbiosis may contribute to inflammation and impaired healing, but sequencing studies have not included African populations and have mainly involved adults. We characterised the skin microbiome of patients with CL in Ethiopia.Methods: In this community-based cross-sectional study in southern Ethiopia, lesion and matched contralateral healthy-skin swabs were collected from clinically diagnosed patients and analysed by 16S rRNA V3–V4 amplicon sequencing. Alpha diversity, beta diversity, and taxonomic composition were compared between paired samples; associations with clinical characteristics were explored.Findings After quality control, 88 samples from 47 patients were retained, including 41 lesion–healthy skin pairs. Thirty-two (68%) patients were younger than 14 years. Lesions had lower observed richness, Shannon diversity, and Simpson diversity than healthy skin (all p<0·0001). Community composition differed modestly (PERMANOVA R²=0·065, p=0·001), although dispersion also differed (PERMDISP p=0·036). Staphylococcaceae and Streptococcaceae each comprised more than 25% of the bacterial community in 16 (39%) and 14 (34%) lesions, respectively. No clear associations were found with lesion characteristics or previous traditional treatment.Interpretation: The consistent reduction in bacterial diversity and enrichment of opportunistic taxa across endemic settings suggest that lesion-associated dysbiosis is a recurring feature of cutaneous leishmaniasis. These findings extend current evidence to an African and predominantly paediatric population and support investigating whether the skin microbiome contributes to lesion persistence or could be targeted alongside antileishmanial treatment.
- 3 August 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLesion Associated Bacterial Dysbiosis in Patients with Cutaneous Leishmaniasis in Ethiopia
Background: Cutaneous leishmaniasis (CL) is a chronic skin disease frequently complicated by bacterial superinfection and poor treatment outcomes. Lesion-associated bacterial dysbiosis may contribute to inflammation and impaired healing, but sequencing studies have not included African populations and have mainly involved adults. We characterised the skin microbiome of patients with CL in Ethiopia.Methods: In this community-based cross-sectional study in southern Ethiopia, lesion and matched contralateral healthy-skin swabs were collected from clinically diagnosed patients and analysed by 16S rRNA V3–V4 amplicon sequencing. Alpha diversity, beta diversity, and taxonomic composition were compared between paired samples; associations with clinical characteristics were explored.Findings After quality control, 88 samples from 47 patients were retained, including 41 lesion–healthy skin pairs. Thirty-two (68%) patients were younger than 14 years. Lesions had lower observed richness, Shannon diversity, and Simpson diversity than healthy skin (all p<0·0001). Community composition differed modestly (PERMANOVA R²=0·065, p=0·001), although dispersion also differed (PERMDISP p=0·036). Staphylococcaceae and Streptococcaceae each comprised more than 25% of the bacterial community in 16 (39%) and 14 (34%) lesions, respectively. No clear associations were found with lesion characteristics or previous traditional treatment.Interpretation: The consistent reduction in bacterial diversity and enrichment of opportunistic taxa across endemic settings suggest that lesion-associated dysbiosis is a recurring feature of cutaneous leishmaniasis. These findings extend current evidence to an African and predominantly paediatric population and support investigating whether the skin microbiome contributes to lesion persistence or could be targeted alongside antileishmanial treatment.
- Open Access
- 26 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Decentralizing care for cutaneous leishmaniasis and other skin diseases to primary health facilities in Southern Ethiopia: What are the needs?
Cutaneous leishmaniasis (CL) and other skin diseases impose a high disease burden in Ethiopia, yet access to care is poor due to limited and centralized di
- 26 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessDecentralizing care for cutaneous leishmaniasis and other skin diseases to primary health facilities in Southern Ethiopia: What are the needs?
Cutaneous leishmaniasis (CL) and other skin diseases impose a high disease burden in Ethiopia, yet access to care is poor due to limited and centralized di
- Open Access
- 5 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages
Plasmodium vivax elimination is challenged by dormant liver stages (hypnozoites) that can reactivate months after initial infection resulting in relapses. Relapsing infections confound antimalarial clinical efficacy trials due to the inability to distinguish between recurrences arising from blood-stage treatment failure (recrudescence), reinfection or relapse. Genetic relatedness of paired parasite isolates, measured by identity-by-descent (IBD), can provide important information on whether individuals have had single or multiple mosquito inoculations, thus informing on recurrence origin. We developed a high-throughput amplicon sequencing assay comprising 93 multi-SNP (microhaplotype) markers to determine IBD between P. vivax clinical isolates. The assay was evaluated in 745 global infections, including 128 infection pairs from a randomized controlled trial (RCT) (ClinicalTrials.gov NCT01680406). Simulations demonstrate low error in pairwise IBD estimation at the panel (RMSE < 0.12) and IBD-based networks illustrate strong clustering by geography. IBD analysis in the RCT demonstrates a lower frequency of suspected relapses or recrudescence in patients treated with primaquine compared to those without primaquine; the impact is greater when paired with chloroquine than with artemether-lumefantrine. Our results demonstrate the potential to derive new information on P. vivax treatment and transmission using IBD generated by amplicon sequencing data that can be further improved with time-to-event models.
- 5 August 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Open AccessMicrohaplotype deep sequencing assays to capture Plasmodium vivax infection lineages
Plasmodium vivax elimination is challenged by dormant liver stages (hypnozoites) that can reactivate months after initial infection resulting in relapses. Relapsing infections confound antimalarial clinical efficacy trials due to the inability to distinguish between recurrences arising from blood-stage treatment failure (recrudescence), reinfection or relapse. Genetic relatedness of paired parasite isolates, measured by identity-by-descent (IBD), can provide important information on whether individuals have had single or multiple mosquito inoculations, thus informing on recurrence origin. We developed a high-throughput amplicon sequencing assay comprising 93 multi-SNP (microhaplotype) markers to determine IBD between P. vivax clinical isolates. The assay was evaluated in 745 global infections, including 128 infection pairs from a randomized controlled trial (RCT) (ClinicalTrials.gov NCT01680406). Simulations demonstrate low error in pairwise IBD estimation at the panel (RMSE < 0.12) and IBD-based networks illustrate strong clustering by geography. IBD analysis in the RCT demonstrates a lower frequency of suspected relapses or recrudescence in patients treated with primaquine compared to those without primaquine; the impact is greater when paired with chloroquine than with artemether-lumefantrine. Our results demonstrate the potential to derive new information on P. vivax treatment and transmission using IBD generated by amplicon sequencing data that can be further improved with time-to-event models.
- Open Access
Decentralizing care for cutaneous leishmaniasis and other skin diseases in Southern Ethiopia: What are the needs?
Background: Cutaneous leishmaniasis (CL) and other skin diseases impose a high burden in Ethiopia, yet underreporting is common due to limited access to diagnostics and treatment. Decentralizing care could improve this situation but may necessitate substantial changes in the healthcare system. This study assessed the available resources, and healthcare professionals’ knowledge and skills across Southern Ethiopia’s healthcare facilities to inform decentralization plans. Methodology/Principle findings: A cross-sectional study was conducted from May to July 2023 in Gamo Zone, South Ethiopia, including visits to 11 health centers, 4 primary hospitals, and 1 general hospital. Available resources were evaluated, and clinical and laboratory staff’s knowledge and skills were tested through questionnaires focused on CL and other skin diseases. Most facilities had equipment for diagnosis and localized treatment. Adequate hospitalization space and necessary equipment for systemic CL treatment were found in 3 out of 4 primary hospitals but none of the health centers. Consumable and drug shortages were common across all facilities. BSc laboratory technologists scored significantly higher than diploma technicians (29 vs. 15 out of 39, p<0.001). Clinical staff scores varied significantly across education levels (p=0.007), with clinicians scoring the highest (median 33, IQR 31-36), followed by health officers (median 29, IQR 27-32), BSc nurses (median 28, IQR 16-36) and diploma nurses (median 25, IQR 19-29). Notably, no significant differences in median scores were observed between primary hospitals and health centers for both clinical and laboratory staff. Conclusions/Significance: Decentralizing diagnosis and treatment of common skin diseases and localized CL treatment to health centers appears feasible with facility adjustments and continuous staff training. CL cases requiring systemic treatment should be referred to primary hospitals. Strategic efforts to enhance and maintain skills and tackle supply shortages are crucial for successful decentralization. Author Summary: Cutaneous leishmaniasis (CL) and other skin diseases are common in Ethiopia, although many cases remain unreported due to limited access to treatment. This could be improved by providing care at lower healthcare facilities, which may require adjustments. We examined the available resources and (clinical and laboratory) staff skills to diagnose and treat CL and other skin diseases in eleven health centers, 4 primary hospitals, and 1 general hospital in South Ethiopia. All facilities had basic equipment for diagnosis and localized treatment of skin diseases, including CL. However, only primary hospitals had the space and equipment to treat severe CL cases. Consumable and drug shortages were common at all facilities. Staff training needs were evident, with better scores for staff with a higher education. Since skilled staff were distributed across health centers and primary hospitals, overall performance was similar between healthcare levels. Decentralizing the diagnosis and localized treatment of skin diseases in health centers is feasible with minor facility improvements and continuous training for healthcare workers. Severe CL cases who need hospitalization should be referred to primary hospitals. Strong strategies should be developed to enhance and maintain knowledge and skills and to tackle supply shortages for successful decentralization.
Open AccessDecentralizing care for cutaneous leishmaniasis and other skin diseases in Southern Ethiopia: What are the needs?
Background: Cutaneous leishmaniasis (CL) and other skin diseases impose a high burden in Ethiopia, yet underreporting is common due to limited access to diagnostics and treatment. Decentralizing care could improve this situation but may necessitate substantial changes in the healthcare system. This study assessed the available resources, and healthcare professionals’ knowledge and skills across Southern Ethiopia’s healthcare facilities to inform decentralization plans. Methodology/Principle findings: A cross-sectional study was conducted from May to July 2023 in Gamo Zone, South Ethiopia, including visits to 11 health centers, 4 primary hospitals, and 1 general hospital. Available resources were evaluated, and clinical and laboratory staff’s knowledge and skills were tested through questionnaires focused on CL and other skin diseases. Most facilities had equipment for diagnosis and localized treatment. Adequate hospitalization space and necessary equipment for systemic CL treatment were found in 3 out of 4 primary hospitals but none of the health centers. Consumable and drug shortages were common across all facilities. BSc laboratory technologists scored significantly higher than diploma technicians (29 vs. 15 out of 39, p<0.001). Clinical staff scores varied significantly across education levels (p=0.007), with clinicians scoring the highest (median 33, IQR 31-36), followed by health officers (median 29, IQR 27-32), BSc nurses (median 28, IQR 16-36) and diploma nurses (median 25, IQR 19-29). Notably, no significant differences in median scores were observed between primary hospitals and health centers for both clinical and laboratory staff. Conclusions/Significance: Decentralizing diagnosis and treatment of common skin diseases and localized CL treatment to health centers appears feasible with facility adjustments and continuous staff training. CL cases requiring systemic treatment should be referred to primary hospitals. Strategic efforts to enhance and maintain skills and tackle supply shortages are crucial for successful decentralization. Author Summary: Cutaneous leishmaniasis (CL) and other skin diseases are common in Ethiopia, although many cases remain unreported due to limited access to treatment. This could be improved by providing care at lower healthcare facilities, which may require adjustments. We examined the available resources and (clinical and laboratory) staff skills to diagnose and treat CL and other skin diseases in eleven health centers, 4 primary hospitals, and 1 general hospital in South Ethiopia. All facilities had basic equipment for diagnosis and localized treatment of skin diseases, including CL. However, only primary hospitals had the space and equipment to treat severe CL cases. Consumable and drug shortages were common at all facilities. Staff training needs were evident, with better scores for staff with a higher education. Since skilled staff were distributed across health centers and primary hospitals, overall performance was similar between healthcare levels. Decentralizing the diagnosis and localized treatment of skin diseases in health centers is feasible with minor facility improvements and continuous training for healthcare workers. Severe CL cases who need hospitalization should be referred to primary hospitals. Strong strategies should be developed to enhance and maintain knowledge and skills and to tackle supply shortages for successful decentralization.
- Open Access
- 12 December 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (12) , e0284505
Prevalence, severity and associated risk factors of anemia among human immunodeficiency virus-infected adults in Sawla General Hospital, Southern Ethiopia: A facility-based cross-sectional study
Anemia is a significant public health problem in HIV/AIDS patients worldwide. This study is aimed to determine the prevalence of anemia and its risk factors among HIV-infected adults in Sawla General Hospital, southern Ethiopia. A facility-based cross-sectional study involving HIV-infected adults was conducted in ART clinic of Sawla General Hospital from April 01 to May 31, 2019. A systematic random sampling technique was employed to recruit the study participants. Socio-demographic and clinical data were collected using a structured questionnaire and checklist. Hemoglobin concentration from venous blood was determined by HemoCue® 301 analyzer. Descriptive and inferential statistics, by Statistical Package for Social Science version 26.0, were applied; p-values ≤ 0.05 in the multivariable logistic regression analysis were considered statistically significant. A total of 220 HIV-infected adults participated in this study. The prevalence of anemia was 38.6%, from which 90.6, 7.1, and 2.3% are mild, moderate, and severe anemia, respectively. Anemia among HIV-infected adults was significantly associated with CD4 cell count below 200 cells/mm3 (AOR: 4.32; 95% CI: 2.10–8.86), clinical stage III or above (AOR: 4.20; 95% CI: 1.06–16.62), five or more years duration of HIV infection (AOR: 2.32; 95% CI: 1.08–4.94) and BMI below 18.5 kg/m2 (AOR: 3.82; 95% CI: 1.83–8.00). Anemia is a moderate public health problem among the study population. Longer duration of HIV infection, advanced clinical stage, lower CD4 cell count, and BMI are risk factors for anemia. Therefore, early ART enrolment for HIV-infected adults with nutritional support and rigorous monitoring of CD4 cell count are essential to lower the prevalence.
- 12 December 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (12) , e0284505
Open AccessPrevalence, severity and associated risk factors of anemia among human immunodeficiency virus-infected adults in Sawla General Hospital, Southern Ethiopia: A facility-based cross-sectional study
Anemia is a significant public health problem in HIV/AIDS patients worldwide. This study is aimed to determine the prevalence of anemia and its risk factors among HIV-infected adults in Sawla General Hospital, southern Ethiopia. A facility-based cross-sectional study involving HIV-infected adults was conducted in ART clinic of Sawla General Hospital from April 01 to May 31, 2019. A systematic random sampling technique was employed to recruit the study participants. Socio-demographic and clinical data were collected using a structured questionnaire and checklist. Hemoglobin concentration from venous blood was determined by HemoCue® 301 analyzer. Descriptive and inferential statistics, by Statistical Package for Social Science version 26.0, were applied; p-values ≤ 0.05 in the multivariable logistic regression analysis were considered statistically significant. A total of 220 HIV-infected adults participated in this study. The prevalence of anemia was 38.6%, from which 90.6, 7.1, and 2.3% are mild, moderate, and severe anemia, respectively. Anemia among HIV-infected adults was significantly associated with CD4 cell count below 200 cells/mm3 (AOR: 4.32; 95% CI: 2.10–8.86), clinical stage III or above (AOR: 4.20; 95% CI: 1.06–16.62), five or more years duration of HIV infection (AOR: 2.32; 95% CI: 1.08–4.94) and BMI below 18.5 kg/m2 (AOR: 3.82; 95% CI: 1.83–8.00). Anemia is a moderate public health problem among the study population. Longer duration of HIV infection, advanced clinical stage, lower CD4 cell count, and BMI are risk factors for anemia. Therefore, early ART enrolment for HIV-infected adults with nutritional support and rigorous monitoring of CD4 cell count are essential to lower the prevalence.
- Open Access
- 11 February 2023
- Published by SAGE Publications in Clinical Trials
- Vol. 20 (3) , 237-241
Adapting international clinical trials during COVID-19 and beyond
Background: The COVID-19 pandemic and resulting restrictions, particularly travel restrictions, have had significant impact on the conduct of global clinical trials. Our clinical trials programme, which relied on in-person visits for training, monitoring and capacity building across nine low- and middle-income countries, had to adapt to those unprecedented operational challenges. We report the adaptation of our working model with a focus on the operational areas of training, monitoring and cross-site collaboration. The new working model: Adaptations include changing training strategies from in-person site visits with three or four team members to a multi-pronged virtual approach, with generic online training for good clinical practice, the development of a library of study-specific training videos, and interactive virtual training sessions, including practical laboratory-focused training sessions. We also report changes from in-person monitoring to remote monitoring as well as the development of a more localized network of clinical trial monitors to support hybrid models with in-person and remote monitoring depending on identified risks at each site. We established a virtual network across different trial and study sites with the objective to further build capacity for good clinical practice–compliant antimalarial trials and foster cross-country and cross-study site collaboration. Conclusion: The forced adaptation of these new strategies has come with advantages that we did not envisage initially. This includes improved, more frequent engagement through the established network with opportunities for increased south-to-south support and a substantially reduced carbon footprint and budget savings. Our new approach is challenging for study sites with limited prior experience but this can be overcome with hybrid models. Capacity building for laboratory-based work remains difficult using a virtual environment. The changes to our working model are likely to last, even after the end of the pandemic, providing a more sustainable and equitable approach to our research.
- 11 February 2023
- Published by SAGE Publications in Clinical Trials
- Vol. 20 (3) , 237-241
Open AccessAdapting international clinical trials during COVID-19 and beyond
Background: The COVID-19 pandemic and resulting restrictions, particularly travel restrictions, have had significant impact on the conduct of global clinical trials. Our clinical trials programme, which relied on in-person visits for training, monitoring and capacity building across nine low- and middle-income countries, had to adapt to those unprecedented operational challenges. We report the adaptation of our working model with a focus on the operational areas of training, monitoring and cross-site collaboration. The new working model: Adaptations include changing training strategies from in-person site visits with three or four team members to a multi-pronged virtual approach, with generic online training for good clinical practice, the development of a library of study-specific training videos, and interactive virtual training sessions, including practical laboratory-focused training sessions. We also report changes from in-person monitoring to remote monitoring as well as the development of a more localized network of clinical trial monitors to support hybrid models with in-person and remote monitoring depending on identified risks at each site. We established a virtual network across different trial and study sites with the objective to further build capacity for good clinical practice–compliant antimalarial trials and foster cross-country and cross-study site collaboration. Conclusion: The forced adaptation of these new strategies has come with advantages that we did not envisage initially. This includes improved, more frequent engagement through the established network with opportunities for increased south-to-south support and a substantially reduced carbon footprint and budget savings. Our new approach is challenging for study sites with limited prior experience but this can be overcome with hybrid models. Capacity building for laboratory-based work remains difficult using a virtual environment. The changes to our working model are likely to last, even after the end of the pandemic, providing a more sustainable and equitable approach to our research.
- Open Access
- 25 November 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 6811-6814
Buruli Ulcer and Medical Geo-Microbiology
Buruli ulcer is a chronic debilitating infectious disease caused by the pathogen Mycobacterium ulcerans, which can be cured if diagnosed and treated in an early stage. However, advanced cases need antibiotic treatment followed by surgical interventions. In this context, an extremely effective and less expensive treatment modality can be developed by means of an extended topical application of certain selected natural clay minerals, most of the time containing illite-smectite having some iron content. There is a scope for developing the speciality, medical geo-microbiology, which is truly a multidisciplinary one, for finding a cure for the severe and advanced cases of BU.
- 25 November 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 6811-6814
Open AccessBuruli Ulcer and Medical Geo-Microbiology
Buruli ulcer is a chronic debilitating infectious disease caused by the pathogen Mycobacterium ulcerans, which can be cured if diagnosed and treated in an early stage. However, advanced cases need antibiotic treatment followed by surgical interventions. In this context, an extremely effective and less expensive treatment modality can be developed by means of an extended topical application of certain selected natural clay minerals, most of the time containing illite-smectite having some iron content. There is a scope for developing the speciality, medical geo-microbiology, which is truly a multidisciplinary one, for finding a cure for the severe and advanced cases of BU.
- Open Access
- 7 July 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (7) , e0271022
Indoor air microbial load, antibiotic susceptibility profiles of bacteria, and associated factors in different wards of Arba Minch General Hospital, southern Ethiopia
The levels of indoor air microbial load in hospitals are very crucial to the health of patients and health care workers and are to be regularly monitored and maintained at an acceptable level. However, this problem remains overlooked, particularly in developing countries including Ethiopia. A hospital-based cross-sectional study is designed to determine the indoor air microbial load (settle plate technique), microbial isolates (standard microbiological techniques), bacterial susceptibility profiles (Kirby-Bauer disk diffusion technique), and associated factors, in different wards of the title Hospital, southern Ethiopia. An observational checklist was used to collect relevant information related to the associated factors; descriptive and inferential statistics were applied using Statistical Package for Social Sciences (SPSS); p-values ≤ 0.05 in the multivariable analysis were considered statistically significant. The total average bacterial and fungal load of the selected wards was 1914±1081.4 Colony Forming Units (CFU)/m3 (95% CI: 1718.5–2109.48 CFU/m3) and 1533.7±858.8 CFU/m3 (95% CI: 1378.5-1688CFU/m3) respectively. The highest mean bacterial (1914±1081.4 CFU/m3) and fungal (1533.7±858.8 CFU/m3) loads were found in the male surgical and female medical wards respectively. A total of 229 bacterial and 139 fungal isolates were obtained; Gram-positive bacteria were the predominant type, 130 (56.7%), particularly the isolates of Staphylococcus aureus, 46 (20.1%). The predominant fungal isolates were Aspergillus sp., 53(38%). Percentages of multidrug-resistant (MDR), extended-spectrum beta-lactamase (ESBL), and carbapenemase producers respectively were 48.5, 26.5, and 25%. High room crowd index [p = 0.003; Adjusted Odds Ratio (AOR) 12.5 (Confidence Interval (CI) 95%: 2.42–65)], presence of damp/wet materials [p = 0.025; AOR 7 (CI 95%: 1.3–37.4)], intense room traffic [p = 0.004; AOR 9.6 (CI 95%: 1.2–79.3)], inappropriate storage of food and drugs [p = 0.008; AOR 7.5 (CI 95%: 1.7–32)], and unclean environment [p = 0.03; AOR 5.8 (CI 95%: 1.2–28)] showed statistical significance concerning the indoor air microbial loads; most of the wards in Arba Minch General Hospital (AMGH) stand high and not in an acceptable level as per the WHO and the European Commission standards on indoor air microbial load. Periodic air surveillance and infection prevention control programs are required to reduce the transmission of these microbes to inpatients, visitors, and health care workers.
- 7 July 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (7) , e0271022
Open AccessIndoor air microbial load, antibiotic susceptibility profiles of bacteria, and associated factors in different wards of Arba Minch General Hospital, southern Ethiopia
The levels of indoor air microbial load in hospitals are very crucial to the health of patients and health care workers and are to be regularly monitored and maintained at an acceptable level. However, this problem remains overlooked, particularly in developing countries including Ethiopia. A hospital-based cross-sectional study is designed to determine the indoor air microbial load (settle plate technique), microbial isolates (standard microbiological techniques), bacterial susceptibility profiles (Kirby-Bauer disk diffusion technique), and associated factors, in different wards of the title Hospital, southern Ethiopia. An observational checklist was used to collect relevant information related to the associated factors; descriptive and inferential statistics were applied using Statistical Package for Social Sciences (SPSS); p-values ≤ 0.05 in the multivariable analysis were considered statistically significant. The total average bacterial and fungal load of the selected wards was 1914±1081.4 Colony Forming Units (CFU)/m3 (95% CI: 1718.5–2109.48 CFU/m3) and 1533.7±858.8 CFU/m3 (95% CI: 1378.5-1688CFU/m3) respectively. The highest mean bacterial (1914±1081.4 CFU/m3) and fungal (1533.7±858.8 CFU/m3) loads were found in the male surgical and female medical wards respectively. A total of 229 bacterial and 139 fungal isolates were obtained; Gram-positive bacteria were the predominant type, 130 (56.7%), particularly the isolates of Staphylococcus aureus, 46 (20.1%). The predominant fungal isolates were Aspergillus sp., 53(38%). Percentages of multidrug-resistant (MDR), extended-spectrum beta-lactamase (ESBL), and carbapenemase producers respectively were 48.5, 26.5, and 25%. High room crowd index [p = 0.003; Adjusted Odds Ratio (AOR) 12.5 (Confidence Interval (CI) 95%: 2.42–65)], presence of damp/wet materials [p = 0.025; AOR 7 (CI 95%: 1.3–37.4)], intense room traffic [p = 0.004; AOR 9.6 (CI 95%: 1.2–79.3)], inappropriate storage of food and drugs [p = 0.008; AOR 7.5 (CI 95%: 1.7–32)], and unclean environment [p = 0.03; AOR 5.8 (CI 95%: 1.2–28)] showed statistical significance concerning the indoor air microbial loads; most of the wards in Arba Minch General Hospital (AMGH) stand high and not in an acceptable level as per the WHO and the European Commission standards on indoor air microbial load. Periodic air surveillance and infection prevention control programs are required to reduce the transmission of these microbes to inpatients, visitors, and health care workers.
- Open Access
- 11 May 2022
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (5) , e0010406
Variation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the replacement of older erythrocytes with low G6PD activity by reticulocytes and young erythrocytes with higher activity. Aim of this study was to assess the impact of acute malaria on G6PD activity. Selected patients with uncomplicated malaria were recruited in Bangladesh (n = 87), Indonesia (n = 75), and Ethiopia (n = 173); G6PD activity was measured at the initial presentation with malaria and a median of 176 days later (range 140 to 998) in the absence of malaria. Among selected participants (deficient participants preferentially enrolled in Bangladesh but not at other sites) G6PD activity fell between malaria and follow up by 79.1% (95%CI: 40.4 to 117.8) in 6 participants classified as deficient (P. vivax or P. falciparum infection. Overall, 66.7% (4/6) severely deficient participants and 87.2% (34/39) with intermediate deficiency had normal activities when presenting with malaria. These findings suggest that G6PD activity rises significantly and at clinically relevant levels during acute malaria. Prospective case-control studies are warranted to confirm the degree to which the predicted population attributable risks of drug induced haemolysis is lower than would be predicted from cross sectional surveys.
- 11 May 2022
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (5) , e0010406
Open AccessVariation in Glucose-6-Phosphate Dehydrogenase activity following acute malaria
Primaquine and tafenoquine are the only licensed drugs with activity against Plasmodium vivax hypnozoites but cause haemolysis in patients with glucose–6–phosphate dehydrogenase (G6PD) deficiency. Malaria also causes haemolysis, leading to the replacement of older erythrocytes with low G6PD activity by reticulocytes and young erythrocytes with higher activity. Aim of this study was to assess the impact of acute malaria on G6PD activity. Selected patients with uncomplicated malaria were recruited in Bangladesh (n = 87), Indonesia (n = 75), and Ethiopia (n = 173); G6PD activity was measured at the initial presentation with malaria and a median of 176 days later (range 140 to 998) in the absence of malaria. Among selected participants (deficient participants preferentially enrolled in Bangladesh but not at other sites) G6PD activity fell between malaria and follow up by 79.1% (95%CI: 40.4 to 117.8) in 6 participants classified as deficient (P. vivax or P. falciparum infection. Overall, 66.7% (4/6) severely deficient participants and 87.2% (34/39) with intermediate deficiency had normal activities when presenting with malaria. These findings suggest that G6PD activity rises significantly and at clinically relevant levels during acute malaria. Prospective case-control studies are warranted to confirm the degree to which the predicted population attributable risks of drug induced haemolysis is lower than would be predicted from cross sectional surveys.